Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment

Journal of Neuropathology and Experimental Neurology

Volumn 65, Issue 6, 2006, Pages 592-601

  Counts, Scott E ^a   Nadeem, Muhammad ^a   Lad, Shivanand P ^a   Wuu, Joanne ^a   Mufson, Elliott J ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer; Cortex; Drebrin; Mild cognitive impairment; Synaptic; Synaptophysin; Synaptotagmin

Indexed keywords

BRAIN PROTEIN; DREBRIN; SYNAPTOPHYSIN; DREBRINS; NEUROPEPTIDE; SYNAPTOTAGMIN;

ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DENDRITIC SPINE; FRONTAL CORTEX; GERIATRIC PATIENT; HUMAN; HUMAN TISSUE; LANGUAGE DISABILITY; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; NEOCORTEX; NERVE CELL PLASTICITY; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCORING SYSTEM; TEMPORAL CORTEX; AGED; ANALYSIS OF VARIANCE; CADAVER; COMPARATIVE STUDY; FEMALE; FRONTAL LOBE; HOSPITALIZATION; MALE; METABOLISM; METHODOLOGY; PATHOLOGY; TEMPORAL LOBE; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; BLOTTING, WESTERN; COGNITION DISORDERS; FEMALE; FRONTAL LOBE; HUMANS; MALE; NEUROPEPTIDES; POSTMORTEM CHANGES; SEVERITY OF ILLNESS INDEX; SYNAPTOPHYSIN; SYNAPTOTAGMINS; TEMPORAL LOBE;

EID: 33746752209     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-200606000-00007     Document Type: Article

References (59)

1. Masliah E, Terry RD, DeTeresa RM, Hansen LA. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease. Neurosci Lett 1989;103:234-39
2. Scheff SW, DeKosky ST, Price DA. Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol Aging 1990;11:29-37
3. Terry RD, Masliah E, Salmon DP, et al. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30:572-80
4. DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 1990;27:457-64
5. Murthy VN, De Camilli P. Cell biology of the presynaptic terminal. Annu Rev Neurosci 2003;26:701-28
6. Kennedy MB, Beale C, Carlisle HJ, et al. Integration of biochemical signalling in spines. Nat Rev Neurosci 2005;6:423-34
7. Lassmann H, Weiler R, Fischer P, et al. Synaptic pathology in Alzheimer's disease: Immunological data for markers of synaptic and large dense-core vesicles. Neuroscience 1992;46:1-8
8. Davidsson P, Blennow K. Neurochemical dissection of synaptic pathology in Alzheimer's disease. Int Psychogeriatr 1998;10:11-23
9. Shimohama S, Kamiya S, Taniguchi T, et al. Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease. Biochem Biophys Res Commun 1997;236:239-42
10. Hatanpaa K, Isaacs KR, Shirao T, et al. Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease. J Neuropathol Exp Neurol 1999;58:637-43
11. Mukaetova-Ladinska EB, Garcia-Siera F, Hurt J, et al. Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. Am J Pathol 2000;157:623-36
12. Masliah E, Mallory M, Alford M, et al. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology 2001;56:127-29
13. Minger SL, Honer WG, Esiri MM, et al. Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease. J Neuropathol Exp Neurol 2001;60:929-36
14. Yao PJ, Zhu M, Pyun EI, et al. Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease. Neurobiol Dis 2003;12:97-109
15. Reddy PH, Mani G, Park BS, et al. Differential loss of synaptic proteins in Alzheimer's disease: Implications for synaptic dysfunction. J Alzheimers Dis 2005;7:103-17; discussion 173-80
16. Bennett DA, Schneider JA, Bienias JL, et al. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology 2005;64:834-41
17. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183-94
18. Counts SE, Nadeem M, Wuu J, Ginsberg SD, Saragovi HU, Mufson EJ. Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease. Ann Neurol 2004;56:520-31
19. Peng S, Wuu J, Mufson EJ, et al. Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer's disease. J Neuropathol Exp Neurol 2004;63:641-49
20. DeKosky ST, Ikonomovic MD, Styren SD, et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 2002;51:145-55
21. Goldstein LB, Samsa GP. Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. Stroke 1997;28:307-10
22. Bennett DA, Shannon KM, Beckett LA, et al. Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale. Neurology 1997;49:1580-87
23. Welsh KA, Butters N, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology 1994;44:609-14
24. Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia: Lea and Febiger, 1983
25. Wechsler D. Wechsler Memory Scale-Revised Manual. San Antonio, TX:Psychological Corp, 1987
26. Smith A. Symbol Digit Modalities Test Manual-Revised. Los Angeles: Western Psychological Services, 1982
27. Raven JC, Court JH, Raven J. Manual of Raven's Progressive Matrices and Vocabulary Scales. Oxford, UK: Oxford University Press, 1992
28. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state.' A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98
29. Wilson RS, Beckett A, Barnes LL, et al. Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging 2002;17:179-93
30. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44
31. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-92
32. Association AP. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association, 1987
33. Mufson EJ, Chen EY, Cochran EJ, Beckett LA, Bennett DA, Kordower JH. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp Neurol 1999;158:469-90
34. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86
35. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59
36. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997;18:S1-2
37. Nieto A, Montejo de Garcini E, Avila J. Altered levels of microtubule proteins in brains of Alzheimer's disease patients. Acta Neuropathol (Berl)1989;78:47-51
38. Sze CI, Bi H, Kleinschmidt-DeMasters BK, et al. Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brains. J Neurol Sci 2000;175:81-90
39. Masliah E, Terry RD, Alford M, et al. Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. Am J Pathol 1991;138:235-46
40. Honer WG, Dickson DW, Gleeson J, et al. Regional synaptic pathology in Alzheimer's disease. Neurobiol Aging 1992;13:375-82
41. Pennuto M, Bonanomi D, Benfenati F, et al. Synaptophysin I controls the targeting of VAMP2/synaptobrevin II to synaptic vesicles. Mol Biol Cell 2003;14:4909-19
42. Sudhof TC. The synaptic vesicle cycle. Annu Rev Neurosci 2004;27:509-47
43. Yoshihara M, Littleton JT. Synaptotagmin I functions as a calcium sensor to synchronize neurotransmitter release. Neuron 2002;36:897-908
44. Shirao T, Kojima N, Kato Y, et al. Molecular cloning of a cDNA for the developmentally regulated brain protein, drebrin. Brain Res 1988;464:71-74
45. Shirao T, Inoue HK, Kano Y, et al. Localization of a developmentally regulated neuron-specific protein S54 in dendrites as revealed by immunoelectron microscopy. Brain Res 1987;413:374-78
46. Hayashi K, Ishikawa R, Ye LH, et al. Modulatory role of drebrin on the cytoskeleton within dendritic spines in the rat cerebral cortex. J Neurosci 1996;16:7161-70
47. Aoki C, Sekino Y, Hanamura K, et al. Drebrin A is a postsynaptic protein that localizes in vivo to the submembranous surface of dendritic sites forming excitatory synapses. J Comp Neurol 2005;483:383-402
48. Takahashi H, Sekino Y, Tanaka S, Mizui T, Kishi S, Shirao T. Drebrin-dependent actin clustering in dendritic filopodia governs synaptic targeting of postsynaptic density-95 and dendritic spine morphogenesis. J Neurosci 2003;23:6586-95
49. Takahashi H, Mizui T, Shirao T. Down-regulation of drebrin A expression suppresses synaptic targeting of NMDA receptors in developing hippocampal neurones. J Neurochem 2005;Nov 21 [Epub ahead of print]
50. Shim KS, Lubec G. Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome. Neurosci Lett 2002;324:209-12
51. Harigaya Y, Shoji M, Shirao T, et al. Disappearance of actin-binding protein, drebrin, from hippocampal synapses in Alzheimer's disease. J Neurosci Res 1996;43:87-92
52. Van Hoesen GW, Hyman BT, Damasio AR. Cell-specific pathology in neural systems of the temporal lobe in Alzheimer's disease. Prog Brain Res 1986;70:321-35
53. Arnold SE, Hyman BT, Flory J, et al. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1991;1:103-16
54. Callahan LM, Coleman PD, Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease. Neurobiol Aging 1995;16:311-14
55. Ginsberg SD, Hemby SE, Lee VM, et al. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol 2000;48:77-87
56. Ingelsson M, Fukumoto H, Newell KL, et al. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 2004;62:925-31
57. Bowen DM, Benton S, Spillane JA, et al. Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients. J Neurol Sci 1982;57:191-202
58. Davis KL, Mohs RC, Marin D, et al. Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA 1999;281:1401-6
59. Honer WG. Pathology of presynaptic proteins in Alzheimer's disease: More than simple loss of terminals. Neurobiol Aging 2003;24:1047-62